• 5 top-paying industries for pharmacists

    On average, general hospitals pay pharmacists more than retailers, but both industries are not among the five highest paying for the profession, according to data from the Bureau of Labor Statistics.
  • Transform Your Hospital Operations: A Virtual Summit

    Sponsored
    Nearly 190 health systems are reimagining hospital operations with AI. Learn how, here.
  • FDA approves antibiotic for 3 uses

    On April 3, the FDA approved Zevtera, an antibiotic with three different uses. 
  • CVS expands financial assistance for pharmacy students

    CVS Health on April 3 unveiled a new tuition assistance program for pharmacy interns and a scholarship program for students in pharmacy school. 
  • A 'crystal ball prediction' for more 340B protections: ASHP expert

    More than 25 states have enacted laws designed to protect against pharmacy benefit managers' discriminatory practices in the 340B program, the American Society of Health-System Pharmacists said April 2. 
  • HHS pitches rewards for hospitals with drug shortage solutions

    Every year, U.S. hospitals spend at least $600 million to mitigate drug shortages, according to HHS. On April 2, the department proposed financial incentives for hospitals with resilient drug supplies. 
  • 3 drugmakers announce recalls

    In the past week, three pharmaceutical companies have recalled medications because of patient safety concerns. 
  • Amazon Pharmacy expands same-day delivery

    Amazon Pharmacy is now offering same-day prescription medicine deliveries for customers in New York City and Los Angeles, with plans to expand to more than a dozen cities by the end of the year.
  • 10 drugs now in shortage

    Since March 20, 10 more drugs are either in short supply or discontinued — and the healthcare supply chain industry is watching whether the collapse of a Baltimore bridge might cause disruptions. 
  • 20 pharmacist- and dermatologist-recommended health products

    On March 28, U.S. News & World Report released its latest over-the-counter medicine and health products ranking.
  • Minnesota system adopts ScripTalk

    Essentia Health, a 14-hospital system based in Duluth, Minn., launched a free tool March 26 to verbalize prescription labels. 
  • Zepbound in shortage

    Patients, pharmacists and physicians are reporting a strained supply of Zepbound, Eli Lilly's new weight loss drug, as the drugmaker and the FDA say the medication is available, according to Bloomberg. 
  • FDA hands warning to New York hospital's drug researcher

    FDA investigators said they found "objectionable conditions" during medication research at Columbia University Medical Center Kreitchman PET Center, according to a warning letter published March 26. 
  • FDA inspections in hospitals on decline due to shortages: Report

    During a yearslong dip of the FDA inspecting clinical research in hospitals and other care sites, the U.S. Government Accountability Office said the agency should bolster its retention and recruitment efforts. 
  • Amgen sues Colorado for potential price limit on arthritis drug

    Five months before Colorado's Prescription Drug Affordability Board will vote on how much to cap the cost of Amgen's Enbrel, the drugmaker filed a lawsuit.
  • FDA approves Merck drug for rare lung disorder

    On March 26, the FDA approved a drug from Merck to treat adults with pulmonary arterial hypertension — a rare, progressive lung condition. 
  • CVS workers in Las Vegas 1st to seek unionization

    About 30 pharmacists and pharmacy technicians at a Las Vegas CVS Omnicare filed to unionize March 25, making them the first in their industry to seek unionization. 
  • The new COVID-19 drug: 4 notes

    More than a year after the FDA yanked away authorization from Evusheld, a monoclonal antibody treatment for COVID-19, the agency granted emergency use authorization to a new COVID-19 preventive drug March 22. 
  • Novo Nordisk to buy heart drugmaker for $1.1B

    Wegovy and Ozempic maker Novo Nordisk has agreed to buy Cardior Pharmaceuticals for $1.11 billion. The acquisition is part of Novo Nordisk's larger strategy to build a portfolio of therapies in cardiovascular disease. 
  • UHS opens new pharmacy in old CVS building

    A former CVS location is now occupied by a United Health Services pharmacy. 
  • FDA OKs a new COVID-19 prevention drug

    On March 22, the FDA granted emergency use authorization to Pemgarda, a COVID-19 preventive medication, for patients 12 and older. 

Articles We Think You'll Like

 

Featured Whitepapers

Featured Webinars